HealthQuill South Korea
Eisai Co., and Biogen Inc., announced that their drug to treat Alzheimer’s disease and cognitive impairment has been approved in Japan.
Drugs Health Pharma

Japan approves Eisai Co, Biogen Inc’s Leqembi for Alzheimer’s 

HQ Team September 25, 2023: Eisai Co., and Biogen Inc., announced that their drug to treat Alzheimer’s disease and cognitive impairment has been.

Read More
The Middle East Respiratory Syndrome Coronavirus has killed 12 people in the UAE and infected 94 others from July 10, when the first case was reported, according to the WHO.
Drugs Health Pharma

MERS-Coronavirus kills 12 people in the United Arab Emirates   

HQ Team July 25, 2023: The Middle East Respiratory Syndrome Coronavirus has killed 12 people in the UAE and infected 94 others from.

Read More
Japan’s Eisai Co and Biogen Inc., have submitted a marketing authorisation application with the South Korean health authority for leqembi, an investigational drug to treat early onset of Alzheimer’s disease.
Drugs Health Medical Pharma

Japan’s Eisai seeks marketing nod for Alzheimer’s drug in South Korea

HQ Team June 8, 2023: Japan’s Eisai Co and Biogen Inc., have submitted a marketing authorisation application with the South Korean health authority.

Read More
Cholera oral vacccine
Drugs Health Medical Pharma

Biovac signs deal for oral cholera vaccine with S.Korea’s IVI

Biovac, a South Africa-based biotechnology company, has signed a technology transfer agreement with a South Korean institute to make an oral cholera vaccine.

Read More
X